|
MechanismHIV-1 integrase inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CA |
First Approval Date21 Sep 2020 |
|
MechanismHIV envelope protein gp120 inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date02 Jul 2020 |
|
MechanismHIV-1 integrase inhibitors [+1] |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CA |
First Approval Date18 Mar 2020 |
100 Clinical Results associated with VIIV Healthcare SRL
0 Patents (Medical) associated with VIIV Healthcare SRL
100 Deals associated with VIIV Healthcare SRL
100 Translational Medicine associated with VIIV Healthcare SRL